Mono-biotinylated Pt IV complex with one hydroxyl ligand in the axial position shows potent inhibition against cisplatin-insensitive breast cancer cells.
No takes yet. Share an insight, caveat, or question.
Nafees et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: